东峰集团(601515) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥358,043,731.12, a decrease of 37.06% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥60,275,808.22, reflecting a significant decline of 180.21% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥51,575,088.67, a decrease of 271.72% compared to the previous year[2]. - The weighted average return on net assets was -1.10%, a decrease of 181.58 percentage points year-on-year[2]. - The basic earnings per share for the period was -¥0.03, compared to -¥0.10 for the year-to-date[2]. - The total equity attributable to shareholders decreased by 4.40% to ¥5,460,222,978.75 compared to the previous year[3]. - The company's operating revenue for the current reporting period decreased by 37.06% due to significant changes in business structure and a sharp decline in tobacco business revenue[5]. - The net profit attributable to shareholders for the year-to-date period decreased by 180.21%, primarily impacted by a substantial decline in the valuation of investment projects and a significant drop in tobacco business revenue[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date period decreased by 271.72%, reflecting the strategic transition and weak performance in the industry[5]. - The basic earnings per share for the year-to-date period decreased by 176.92% compared to the previous year, driven by the decline in net profit attributable to shareholders[6]. - The weighted average return on net assets for the year-to-date period was -181.58%, indicating a significant downturn in financial performance[6]. - The company reported a significant reduction in cash paid to employees, totaling ¥211,616,319.30 in the first three quarters of 2024, down from ¥381,345,457.41 in the same period of 2023[16]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,911,705,468.29, down 6.69% from the end of the previous year[2]. - As of September 30, 2024, the total assets of the company amounted to RMB 6,911,705,468.29, a decrease from RMB 7,407,177,651.11 at the end of 2023, reflecting a decline of approximately 6.7%[10]. - The company's current assets totaled RMB 3,053,949,102.31, down from RMB 3,658,947,385.18, indicating a decrease of about 16.5%[10]. - The company's total liabilities decreased to CNY 1,257,903,245.65 from CNY 1,348,578,429.85 year-over-year, a reduction of approximately 6.7%[12]. - The total equity attributable to shareholders of the parent company decreased to CNY 5,460,222,978.75 from CNY 5,711,424,032.00, a decline of about 4.4%[12]. - The total assets decreased to CNY 5,675,573,393.74 from CNY 5,919,168,321.37, reflecting a decline of approximately 4.1%[20]. - The total liabilities decreased to CNY 431,603,029.37 from CNY 470,938,244.25, indicating a reduction of about 8.3%[20]. - The company's deferred income tax assets decreased to CNY 101,749,026.35 from CNY 129,895,063.31, a decline of approximately 21.6%[19]. - The total equity decreased to CNY 5,243,970,364.37 from CNY 5,448,230,077.12, a decline of approximately 3.8%[20]. Cash Flow - The company reported a net cash flow from operating activities of ¥6,960,332.02 year-to-date[2]. - In the first three quarters of 2024, the company generated cash inflows from operating activities totaling ¥1,120,279,065.44, a decrease of 50.7% compared to ¥2,273,526,334.10 in the same period of 2023[16]. - The net cash flow from operating activities for the first three quarters of 2024 was ¥6,960,332.02, a significant improvement from a net outflow of ¥44,169,829.02 in the first three quarters of 2023[16]. - The company reported cash outflows from investing activities totaling ¥551,506,686.13 in the first three quarters of 2024, compared to ¥482,351,847.57 in the same period of 2023[17]. - The net cash flow from investing activities was negative at ¥368,325,259.44 for the first three quarters of 2024, contrasting with a positive cash flow of ¥57,224,261.31 in the same period of 2023[17]. - The company received cash from financing activities totaling ¥187,887,636.15 in the first three quarters of 2024, compared to ¥82,901,298.30 in the same period of 2023[17]. - The net cash flow from financing activities was positive at ¥72,061,103.83 for the first three quarters of 2024, compared to a mere ¥1,405,591.25 in the same period of 2023[17]. - The net cash flow from operating activities for the first three quarters of 2024 is CNY 22,449,974.78, a significant decrease of 92.56% compared to CNY 302,131,762.30 in the same period of 2023[24]. - The net cash flow from financing activities was negative at CNY -509,458,410.07, worsening from CNY -334,025,685.15 in 2023[24]. Research and Development - Research and development expenses for the first three quarters of 2024 were CNY 66,140,572.15, down from CNY 102,436,004.55 in the same period of 2023, representing a decrease of 35.4%[13]. - Research and development expenses for the first three quarters of 2024 were CNY 5,301,973.04, down 45.5% from CNY 9,712,136.25 in the same period of 2023[22]. Strategic Transition - The company is currently in a strategic transition phase, focusing on new material and Class I pharmaceutical packaging businesses, leading to substantial changes in its business structure[5]. - The company is experiencing intensified competition within its industry, which has further impacted its financial results[5].